Ismaël Nujurally - CEO
Ismaël joined Theraclion in 2007. He is a Medical Doctor specialized in Emergency Medicine and holds a degree in marketing with over 20 years of experience in the sector of innovative medical device technology. He has held national, international and general management positions within major companies such as Abbott France, Bard France, American Medical Systems, Tyco France, Oxford Instruments/Viasys Healthcare and Credes Limited.

François Lacoste - Founder and Chief Scientific Officer
François has 25 years experience as an engineer in R&D for projects in the field of non-invasive therapies using physical agents. At Edap Technomed, where he headed R&D for 15 years, he instigated HIFU projects, notably the thyroid project.

David Del Bourgo - Business Development Director
Prior to joining Theraclion in 2009, David was Director of Corporate Development at Orbotech Ltd. His experience includes strategic consulting, as well as 7 years at GE Healthcare in Global Marketing and Engineering. He holds an MBA from the University of Chicago and a Master of Science from the University of Technology of Compiègne, France.

Sylvain Yon - VP Research & Development
Sylvain joined Theraclion in January 2009. In 2001he cofounded Echosens a company dedicated to the diagnostic of liver fibrosis and led the engineering activities of the company. Previously, he contributed to the creation of a company working on acoustic wave propagation. He also worked as an assistant professor at the French Navy Officers School. Sylvain holds a Doctorate in Physical Acoustics from the Paris VII University and a degree in Engineering from ESPCI.

●  Jean-Yves Burel - Chairman of the Board
    Jean-Yves is a former GE executive with 23 years of experience at GE Healthcare,     in particular as Vice-President Hospital and Healthcare Solutions, Commercial,
    Operations and Sales.

●  Dr. Ismaël Nujurally, Chief Executive Officer

●  Dr. Philippe Pouletty, Truffle Capital,
    Co-Founder and General Partner, Life Sciences

●  Pr. Tilman Drueke, Doctor in Nephrology; Director of INSERM Unit 90,
    Necker Hospital, Paris, France

●  Dr. Lazlo Hegedus, Endocrinologist, Odense University, Denmark

●  Amy  Paul, Former group executive Vice-President CR Bard